Kingstone Q4 2025 slides: record profitability amid revenue challenges

Q4 EPS $1.03 crushed the $0.56 consensus (+83.9%) while revenue of $56.42M missed by 31.8% vs $82.7M, and the stock fell ~5.6% after-hours. Full-year EPS $2.88 (+95% YoY), annualized ROE 51.3%, book value/share +75% to $8.28, total equity $122.7M (+84%), zero net debt and dividend reinstated at $0.05. Management guides FY26 direct premiums written +16–20%, net combined ratio 85–90% and diluted EPS $2.38 (assumes a 6.5ppt catastrophe load), leaving investors concerned about top-line sustainability despite strong underwriting and efficiency gains.

Analysis

The market is re-rating this franchise around durability of growth rather than underwriting quality; that creates a two-way trade where incremental premium flow is the marginal valuation driver. If new-business capture and re-underwriting deliver as marketed, earnings volatility from catastrophe normalization will be absorbed and multiples should expand; conversely, any sustained drag in new premium formation or higher-than-assumed ceding costs will compress the multiple quickly because the company’s moat is increasingly expressed through scale and distribution rather than sticky short-tail economics alone.

Second-order winners include analytics vendors and brokers that accelerate policy conversion (they gain leverage from an insurer that centralizes risk segmentation), while reinsurers and capital providers stand to tighten pricing if the carrier pushes into higher-loss geographies or concentrates retention. Expansion into a regulated new state introduces political and rate-filing execution risk that can delay premium recognition by quarters and force reinsurance tweaks — both are asymmetric catalysts for volatility rather than slow steady value creation.

Key near-term catalysts to watch are sequential new-business metrics, quota-share program amendments, and first-event loss experience during the upcoming catastrophe season; any of these can swing consensus EPS materially within three to nine months. Over 12–36 months the trade resolves on whether underwriting tech and targeted acquisitions scale without adverse selection; plan sizing should assume potential 30–40% downside in a stress scenario where growth stalls and catastrophe load reverts up, vs 30–60% upside if top-line acceleration and benign loss picks persist and the stock re-rates.

Key Decisions for Investors

• Tactical long equity (KINS) — 2–4% portfolio position sized for recovery: add on sequential new-business prints and maintain a hard stop at 20% downside; target 30–40% upside over 9–12 months if premium momentum and combined-ratio guidance trend favorably (R/R ~1.5–2x).
• Directional options: buy Jan 2027 LEAP calls ~25% OTM (2x notional vs desired equity exposure) financed by selling 3–6 month calls ~10% OTM to collect premium and reduce cost; this expresses a 12–18 month view on execution while monetizing near-term investor skepticism. Protect with a 20% trailing stop on the long LEAP notional.
• Pair trade to isolate execution: long KINS / short insurance index (e.g., KIE) sized to net neutral market beta — this isolates company-specific re-rating potential. Trim if industry-wide loss chatter or reinsurance rate shifts drive the index; target asymmetric payoff where company-specific upside outpaces sector.
• Event hedge: buy 3–6 month puts (1/4th notional vs equity position) ahead of the next catastrophe season and key state-entry milestones to cap headline risk; acceptable hedge cost up to 1.5% of portfolio for those seeking to keep directional exposure.